Carcinogenesis in the Thyroidectomized Rat: The Effect of Injected Growth Hormone by Bielschowsky, F.
231
CARCINOGENESIS IN THE THYROIDECTOMIZED RAT
THE EFFECT OF INJECTED GROWTH HORMONE
F. BIELSCHOWSKY
From the Hugh Adam Cancer Research Department of the Medical School and the New
Zealand Branch of the British Empire Cancer Campaign, University of Otago, Dunedin
Received for publication February 7, 1958
AMINOFLUORENE (A.F.) in amounts that induce hepatomas or cholangiomas
in more than 80 per cent of intact and castrated male rats is not carcinogenic
for the liver of thyroidectomized animals. Tumours of other organs, however,
can still be obtained after ablation of the thyroid (Bielschowsky and Hall, 1953).
It remained to be investigated whether the protection of the liver against the
aromatic amine was due to the lack of thyroid hormones or to the absence of a
pituitary factor, since the adenohypophysis of such rats is known to be void of
acidophilic elements. This paper deals with the response to A.F. of thyroidec-
tomized rats injected with growth hormone.
METHODS
Male albino rats belonging to the same stock used in earlier experiments were
thyroidectomized at the age of 6 weeks. Two months later, when completely
and partially thyroidectomized animals could be distinguished by their weight
cuirves, treatment was started. The final criterionfor completeness ofthe operation
was, however, the cytological picture of the pituitary. A 4 per cent solution of
A.F. in acetone was painted on to the interscapular region 3 times per week.
A total of 70 doses was given. The growth hormone, a gift of Frederiksberg
Chemical Laboratories, was dissolved in 0-25 per cent acetic acid and injected
intraperitoneally 6 times per week. The schedule of injections was as follows:
in Experiment I during 8 weeks daily doses of2 mg. were given. This was followed
by 6 injections of 4 mg. in the 9th week. In Experiment II the first 3 injections
were of 1 mg. each, the 4th to 24th of 2 mg., the 25th to 36th of 4 mg. After an
interval of 10 days 24 additional doses of 4 mg. and finally 6 of 8 mg. were
administered. Treatment with A.F. and somatotrophin started on the same day.
The histological methods used were those previously described (Bielschowsky
and Hall, 1953).
RESULTS
Experiment I was terminated in the 58th and II in the 42nd week. The
animals were killed when palpable tumours were present or when rapidly declining
health made further survival unlikely. As expected from previous experience,
treatment with A.F. failed to induce tumours in the livers ofcompletely thyroidec-
tomized rats, but in animals in which ablation of the thyroid was incomplete,
all signs of A.F. action were found, namely gross enlargement of the organ asF. BIELSCHOWSKY
well as neoplastic lesions. The weights of the livers of completely thyroidec-
tomized rats treated with growth hormone and A.F. were found to be of a similar
order of magnitude to those of athyreotic rats not injected with somatrophin,
whether or not hepatomas were present. In Table I the values are given in
TABLE I
Experiment I
f -A--
Experiment II
f,
A
_
Thyroidectomy Complete Complete Incomplete Complete Complete Incoml
Treatment. . . A.F.+G.H. A.F. A.F. A.F.+G.H. A.F. AX
Number of rats . . 5 5 2 . 5 5 4
Average liver weight . 6-6 g. 7*6 g. 15-1 g. . 5-8 g. 6 6 g. 20-0
Liver tumours-
Ben. cholang.* . 2 . 1 - 1
Adenomas . 1 1 . 1 - 1
Hepatomas . . - 1 . 3 - 2
Extrahepatictumours 2 1 2 . 2 2 1
G.H. = Growth hormone.
* Benign cholangiomas are recorded only when no other type of liver tumour was present.
plete
F.
g.
gramsand not in percentage ofbodyweight because many ofthe thyroidectomized
rats became obese during the later part of the experiment. The neoplasms were
classified as hepatomas, adenomas and benign cholangiomas according to their
histological structure. It is not always possible to distinguish macroscopically
the benign from the malignant type of liver cell nodule. Fig. 1 and 2 depict
their distinctive features. The benign cholangiomas are easily recognizable
by their cystic appearance.
It seems as if in the first experiment either the duration of treatment with
growth hormone or the amounts given were inadequate to overcome the protection
that complete ablation of the thyroid confers on the liver. Only a few benign
neoplastic lesions of small size were obtained in this organ. With the larger
doses of Experiment II, besides such benign tumours, 3 of the 5 completely
thyroidectomized males developed hepatomas the largest of which measured
11 x 10 x 9 mm. This was found in a rat with a body weight of 200 g. and a
liver weight of 5-8 g. The animal was killed in the 37th week ofthe experiment,
i.e. at a time when hepatomas develop in intact animals painted with A.F. Signs
of liver damage such as increase in connective tissue and proliferation of bile
ducts were, on the whole, most pronounced in rats with residual thyroid tissue
and least in completely thyroidectomized animals treated with A.F. only.
However, the period of survival after the administration of the carcinogen had
been stopped varied by several weeks and so did the degree of obesity with
concomitant accumulation of fat in the liver. From the material available it is
impossible to assess accurately the degree of injury to the liver in the animals of
the 3 groups.
EXPLANATION OF PLATE
FIG. 1.-Adenoma found in completely thyroidectomized rat injected with growth hormone
(Experiment I). Tumour cells are small with slightly basophilic cytoplasm. H. and E.
x 150.
FIG. 2.-Hepatoma found in completely thyroidectomized rat injected with growth hormone.
(Experiment II). H. and E. x 150.
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As in the previous experiments the majority of the extrahepatic tumours
were carcinomas ofthe meatus acousticus.
DISCUSSION
The work of Griffin, Richardson, Robertson, O'Neal and Spain (1955),
Firminger and Morris (1955), Skoryna (1955) and Hoffman (1956) (quoted from
Weisburger and Weisburger, 1957) and of O'Neal and Griffin (1957) has firmly
established that carcinogenic azo-dyes as well as 2-aminofluorene derivatives
fail to induce liver tumours inhypophysectomized rats. Ablation ofthe pituitary,
however, does not protect other susceptible organs against the tumour-inducing
action of N-2-fluorene diacetamide, just as thyroidectomy protects only the liver
of rats treated with A.F. Attempts to restore the susceptibility of the liver
of hypophysectomized rats to azo-dyes with hormonal preparations of pituitary
origin were successful. Griffin et al. (1955) found ACTH as well as somatotrophin
effective, but the rate of tumour development was slower in hypophysectomized
rats injected with either of these hormones than in intact animals. Hoffman
(1956) using N-2-fluorenyl diacetamide obtained precancerous lesions in the livers
of hypophysectomized rats treated with growth hormone, but not when ACTH
was injected.
To judge from the histology of the adenohypophysis the athyreotic rat lacks
growth hormone. The results presented in this communication show: it is the
lack ofthis pituitary agent and not the lack ofthyroxine that causes the strikingly
reduced susceptibility of the liver to A.F. in thyroidectomized rats. This inter-
pretation is supported by the findings of Griffin et al. (1955) who could not obtain
liver tumours in hypophysectomized rats injected with thyrotrophic hormone.
SUMMARY
Injection of growth hormone restores the susceptibility of the liver of athy-
reotic rats to A.F.
My thanks are due to Dr. B. H. Loft of the Frederiksberg Chemical Labora-
tories, Copenhagen for a generous gift of growth hormone.
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